Category: antibody

Recombinant antigens and antibodies to Zika virus

The Zika virus envelope colourfully modelled by Amsbio

ZIKA virus is presently causing significant worldwide concern due its rapid spread across the globe and suggested connection to a neurological birth disorder. The outbreak began in Brazil in 2015 and has since spread throughout South and Central America, and…

European distributor for stem cell research products

Eikonix, a Cambridge, UK-based imaging and life science company, has been appointed exclusive distributor for the Stemmera range of stem cell research products. Stemmera is based in California, USA, with products including kits, culture medium, reagents, antibodies, buffers, solutions, and…

Bio-Rad closes deal to buy AbD Serotec

BIO-RAD Laboratories has signed a definitive agreement to acquire AbD Serotec, a supplier of antibodies and reagents, from MorphoSys, for €53 million (about US$70 million) in cash. The transaction is expected to be completed in January 2013. “We are impressed with…

Dengue virus NS1 monoclonal antibodies now available

VIROSTAT has released several new monoclonal antibodies to the NS1 of Dengue virus. These antibodies recognise the NS1 protein of all four Dengue serotypes and are, says the company, powerful tools for researchers and developers of rapid detection methods. Dengue…

Antibodies for Ureaplasma parvum

Ureaplasma are very small free-living bacteria that, like the mycoplasmas, have no cell walls. Named for its metabolic utilisation of urea, it possesses a small simple genome. Ureaplasma parvum is the genus found in the human urogenital tract. Its presence has been associated with several conditions including urethritis, pelvic inflammatory disease, congenital pneumonia and neonatal meningitis. ViroStat introduces a set of new monoclonal antibodies to U parvum that have applications in Elisa and IFA.

Monoclonal antibodies target Herceptin

LATEST addition to the range of anti-idiotypic antibodies from AbD Serotec are used to target Herceptin (Trastuzumab), an anti-cancer drug. The six new antibodies are useful for monitoring patient serum for Herceptin levels, and have potential applications in preclinical research.…